Allergic rhinitis (AR) is a global health problem that has increased rapidly in prevalence over the past few decades. Nasal congestion, which represents a cardinal symptom of AR, appears to be difficult to treat and, especially for pediatric population, therapies that are both well tolerated and effective in relieving nasal congestion are needed. The aim of the present study was to evaluate the safety and clinical effectiveness of the medical device (lactoferrin, carboximetil β-glucan, D-panthenol, dipotassium glycyrrhizinate) in reducing the allergic rhinitis symptoms.
Passali, D., Bellussi, L., Gregori, D., Lauriello, M., Passali, F.m., Passali, G. (2012). Nasal obstruction as a key symptom in allergic rhinitis: efficacy and safety of a medical device in children. OTOLARYNGOLOGIA POLSKA, 66(4), 249-253 [10.1016/j.otpol.2012.05.019].
Nasal obstruction as a key symptom in allergic rhinitis: efficacy and safety of a medical device in children
PASSALI, FRANCESCO MARIA;
2012-01-01
Abstract
Allergic rhinitis (AR) is a global health problem that has increased rapidly in prevalence over the past few decades. Nasal congestion, which represents a cardinal symptom of AR, appears to be difficult to treat and, especially for pediatric population, therapies that are both well tolerated and effective in relieving nasal congestion are needed. The aim of the present study was to evaluate the safety and clinical effectiveness of the medical device (lactoferrin, carboximetil β-glucan, D-panthenol, dipotassium glycyrrhizinate) in reducing the allergic rhinitis symptoms.| File | Dimensione | Formato | |
|---|---|---|---|
|
2012 grip stop 2012.pdf
accesso aperto
Descrizione: articolo pricipale
Dimensione
206.42 kB
Formato
Adobe PDF
|
206.42 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
